Perioperative changes in left ventricular systolic function following surgical revascularization

Michael C Downey1,2, Matthew Hooks1,2, Amy Gravely3

  • 1Division of Cardiology, Minneapolis VA Health Care System, Minneapolis, MN, United States of America.

Plos One
|November 10, 2022
PubMed

Insights

Coronary artery bypass graft surgery (CABG) can improve left ventricular ejection fraction (LVEF) in nearly 26.4% of patients with systolic dysfunction. Improved LVEF after CABG is linked to better long-term survival, especially in those with lower baseline LVEF.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Heart Failure Research

Background:

  • Left ventricular systolic dysfunction affects nearly one-third of patients undergoing coronary artery bypass graft surgery (CABG).
  • The impact of CABG on left ventricular ejection fraction (LVEF) in these patients remains incompletely understood.
  • Limited data exists on the extent, direction, and clinical implications of perioperative LVEF changes.

Purpose of the Study:

  • To investigate perioperative changes in left ventricular ejection fraction (LVEF) among patients with systolic dysfunction undergoing CABG.
  • To identify factors influencing LVEF changes after CABG.
  • To determine the association between LVEF improvement and long-term mortality.

Main Methods:

  • Analysis of 549 patients with left ventricular systolic dysfunction (LVEF <50%) from the STICH trial undergoing CABG.
  • Pre- and post-CABG (4-month) LVEF assessments using identical cardiac imaging, interpreted at a core laboratory.
  • Clinically significant LVEF change defined as an absolute change >10%.

Main Results:

  • 26.4% of patients experienced a >10% improvement in LVEF post-CABG; 67.2% had no significant change; 6.4% had >10% worsening.
  • Lower preoperative LVEF was associated with a higher likelihood of LVEF improvement (OR 1.36).
  • Postoperative LVEF improvement was not influenced by myocardial viability and was linked to a 57% lower risk of all-cause mortality (HR 0.43).

Conclusions:

  • A significant proportion of patients with ischemic cardiomyopathy undergoing CABG show improved LVEF.
  • LVEF improvement is more common in patients with lower baseline LVEF.
  • Post-CABG LVEF improvement is a significant predictor of enhanced long-term survival.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
22
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
32
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31